PubRank

Penelope Miron

Author PubWeight™ 57.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The landscape of cancer genes and mutational processes in breast cancer. Nature 2012 11.24
2 Mutational processes molding the genomes of 21 breast cancers. Cell 2012 11.22
3 The life history of 21 breast cancers. Cell 2012 10.59
4 Breast-cancer risk in families with mutations in PALB2. N Engl J Med 2014 4.97
5 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
6 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
7 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
8 A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 2012 2.45
9 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
10 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011 1.65
11 Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 2013 1.28
12 Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. J Surg Res 2006 1.09
13 BRCA1-IRIS overexpression promotes formation of aggressive breast cancers. PLoS One 2012 0.97
14 Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter. J Biol Chem 2008 0.85
15 Prevalence of germline TP53 mutations in HER2+ breast cancer patients. Breast Cancer Res Treat 2013 0.77